Mobile

A clinical study comparing the effects of chemotherapy plus Avastin to chemotherapy plus Avastin plus a new drug (MEGF0444A) in patients with colorectal cancer that has spread to other parts of the bo...

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-001867-28

A clinical study comparing the effects of chemotherapy plus Avastin to chemotherapy plus Avastin plus a new drug (MEGF0444A) in patients with colorectal cancer that has spread to other parts of the body, who have not received chemotherapy before

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To estimate the efficacy of MEGF0444A used in combination with FOLFOX + bevacizumab therapy in patients with previously untreated mCRC, as measured by progression-free survival (PFS)

Critère d'inclusion

  • PATIENTS WITH PREVIOUSLY UNTREATED METASTATIC COLORECTAL CANCER

Liens